For decades, blood transfusions have been the standard treatment for restoring red blood cells and oxygen delivery in patients suffering substantial blood loss. However, natural alternatives are emerging aimed at replicating transfusion benefits while avoiding risks like incompatibility issues and infections. Here we’ll examine promising new natural alternatives to blood transfusion and why they warrant consideration.
A Brief History of Blood Transfusions
While experiments with animal-human blood swapping date back centuries, the modern era of successful blood transfusions began in the early 1900s with the discovery of blood types and cross-matching. By mid-century, blood banking, screening, and component separation helped make transfusions routine hospital practices for replenishing blood and managing diseases.
However, transfusions also posed risks like viral transmission, bacterial infection, and acute hemolytic reactions. The desire to avoid such complications has driven interest in non-donor alternatives using synthetic or purified substances that mimic the oxygen delivery of red blood cells without the associated risks.
Hemoglobin-Based Oxygen Carriers (HBOCs)
A leading alternative approach uses solutions of stabilized hemoglobin proteins sourced from humans, cows or genetically modified microorganisms. These function as oxygen carriers similar to natural hemoglobin. Unlike normal hemoglobin, HBOCs stay stable when outside red blood cells in free form, resisting kidney filtration.
Researchers have worked to optimize hemoglobin purification, molecular structure, and enclosure in protective shells to avoid toxicity issues that plagued early versions. HBOCs now show promise restoring oxygenation quickly without blood type limits or preservation needs. More trials are underway. If proven safe and effective, they could supplement or replace transfusions.
Perfluorocarbons (PFCs)
PFCs are synthetic liquid compounds that can transport high volumes of oxygen and carbon dioxide without diluting blood components. Being inert, they are biologically stable. While promising, first-generation PFCs lingered in the body too long. Newer PFC formulations reduce persistence so the compound is exhaled after use.
With improved ventilation techniques to accelerate exhalation, PFCs may soon deliver temporary oxygenation during surgery or life-threatening trauma. Already approved for lung lavage procedures, PFCs could find wider use replacing transfusions thanks to universal compatibility.
Stem Cell Therapies
Stem cell treatments introduce another avenue for generating patient-specific red blood cells without donations. Researchers have successfully used hematopoietic stem cells from bone marrow to grow oxygen-carrying red blood cells. Further optimizing cell lines and growth factors may soon make this a renewable source of transfusion-grade red blood cells.
Patient Blood Management (PBM)
Finally, patient blood management (PBM) utilizes pharmaceuticals, devices, and surgical techniques that allow planned surgeries with minimal transfusions. Tranexamic acid limits bleeding, while erythropoietin promotes red blood cell production pre-surgery. Cell salvage systems recover and reinfuse blood lost during operations. With PBM, transfusions become a last resort.
The Takeaway
While transfusions save lives, alternatives offer advantages like universal usability and infection risk reduction. As research continues, we inch closer to options providing transfusion benefits without donor requirements. Until then, physicians can employ PBM strategies to safely avoid allogeneic transfusions when possible. The future is moving beyond whole blood alone.